Hadassah

“Stunning Results” Continue with Hadassah’s Stem Cell Treatment to Reverse MS

Thursday, Sep 15 2016

Prof. Dimitrios Karussis.

The Hadassah Medical Center is continuing to receive positive findings with its Phase II clinical trial using its unique stem cell approach to stop the progression and reversing the disabilities of multiple sclerosis.

The Hadassah-developed treatment involves intrathecal injection--injection of the patient’s own bone marrow-derived stem cells directly into the spinal fluid--so that the cells circulate all the way around the brain and the spinal cord, where they are needed.

Hadassah began its clinical trials with ALS and MS patients in 2007, marking “the first time this approach had been applied in neurological diseases,” explains Principal Investigator Prof. Dimitrios Karussis, head of Hadassah’s Multiple Sclerosis Center. “The safety data were excellent,” he relates. “There was absolutely no serious adverse event, and we saw that, as a secondary observation-- because there was no placebo with which to compare it --patients with ALS stopped progressing for at least six months, the length of the study.”  In addition, he says, “patients with multiple sclerosis sometimes had a significant improvement in their disability.”

Fast forward to 2016 and Prof. Karussis is now optimistic about his Phase II study which began in January 2015. To date, about 2/3 out of the 48 patients to be enrolled have been recruited and treated. “This trial,” explains Prof. Karussis, “is a large, randomized double-blind, placebo-controlled study. While the patients in the control group will not know if they are initially getting the actual treatment or a placebo, the trial contains a crossover design so that eventually everyone will get the stem cell treatment, although some patients will receive the actual treatment six months later.”

Where will these clinical trials lead if they continue to yield positive findings? Prof. Karussis replies:  “We can say that if things continue to go like this and continue in the same direction, this will definitely change the face of neurology and the management of these diseases, which have been very impotent, you could say, all these years.”  Read the full article in The Jerusalem Post

Comments

From: Olayemi Ajala on November 26, 2017
My mum has MS I’m from london she can’t walk or move her legs but can move her arms can I plan to see you I want my Mum to walk again
From: Laura on November 22, 2017
Hello ! can you tell me how you can get on the trial in Israel..its for my lovely husband !! thank you laura
From: Helen on November 5, 2016
I have Lupus and am interested to learn what new Research you might have ready to bring to the market.
From: Grecia on October 21, 2016
What amazing results! Where can I find info about doctor Karussis lecture plans for this year? Thank you!
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Feb 20 2018

Nursing Students Spark Change in ER Experience for Challenged Patients

A physically, cognitively, and emotionally challenged middle-aged man was brought to the Hadassah Hospital Ein Kerem Emergency Room (ER) from the Israel Elwyn residential community, where he has lived for decades.

READ MORE ›
alt_text

Wednesday, Feb 14 2018

Student with MS Running the Jerusalem Marathon to Support Hadassah’s MS Program

Thanks to his physicians at the Hadassah Medical Center, Dov Guggenheim, who was diagnosed with Multiple Sclerosis (MS) in 2015, has gone from “depressed to optimistic, paralyzed to athletic, and, most important, hopeless to hopeful.”

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Texas Tropical Disease Expert Meets with Hadassah Infectious Disease Specialists

Dr. Peter Jay Hotez, renowned professor in the Departments of Pediatrics and Molecular Virology and Microbiology at Houston (Texas) Baylor College of Medicine and Dean of its National School of Tropical Medicine, met with two Hadassah Medical Organization infectious disease specialists to discuss regional cooperation in fighting tropical diseases, such as the now-infamous Zika virus and leishmaniosis, which is contracted from sand flies.

READ MORE ›
alt_text

Wednesday, Feb 7 2018

Large Hadassah Study Identifies Predictor of Greater Risk of End-Stage Renal Disease

The findings of a nationwide study of over a million and a half Israeli adolescents, conducted by researchers at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, suggest that kidney disease in childhood is associated with a significantly increased risk of end-stage renal disease (ESRD) in adulthood, even if kidney function seems normal in adolescence.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More